Product Description
Overall, the Australia DBGS and other biomaterials market was valued at over $25 million in 2023. This is expected to increase over the forecast period at a CAGR of 11% to reach over $53 million.
The full report suite on the Australian market for dental bone graft substitutes (DBGSs) and other biomaterials includes DBGSs, dental barrier membranes and local antimicrobial periodontal treatments. Collectively, these segments will be referred to as the dental biomaterials market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
AUSTRALIA DENTAL BONE GRAFT SUBSTITUTES MARKET TRENDS
- The expanding prevalence of dental implants in Australia is set to propel the overall market for dental biomaterial products. The increasing adoption of dental implants, favored by both dentists and patients for their effective and durable restorative solutions, is a key driver. These implant procedures have a strong correlation with the markets for Dental Bone Grafting Substitutes (DBGS) and dental barrier membranes. The positive momentum created by the amalgamation of implant products with biomaterials is anticipated to exert a favorable impact on the Australian market for DBGS and other biomaterials.
AUSTRALIA DENTAL BONE GRAFT SUBSTITUTES MARKET SHARE INSIGHTS
- In 2023, Geistlich dominated the Australian dental biomaterials market, particularly in the xenograft segment with its Bio-Oss® product line. Despite its historical success, the economic downturn led some clinicians to explore alternative options with broader product lines or lower prices. Geistlich maintained its leading position through the Bio-Gide® collagen membrane, dominating the dental barrier membrane market.
- Australian Biotechnologies gained a significant market share in the allograft segment, propelled by its popular Oravance™ brand, allowing it to achieve the second overall market share position. Regulatory barriers provided a favorable environment, reducing competitive pressures. The products find widespread use in hospitals, contributing to the company’s growth in the allograft market.
- BioHorizons secured the third position in the overall dental biomaterials market in Australia in 2023. Their success is attributed to the MinerOss®, Grafton® DBM, and LADDEC® products, developed by Osteotech. The MinerOss® family offers cortical, cancellous, and mixed allograft versions. Despite being a mid-sized competitor, BioHorizons has exhibited remarkable growth in dental implants and associated regenerative sales.
MARKET SEGMENTATION SUMMARY
- Dental Bone Graft Substitute (DBGS) Market – The market analysis is further broken down into segments by:
- Type: Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, Synthetics.
- Application*: Socket Preservation, Sinus Augmentation, Ridge Augmentation, Periodontal Procedure.
- Dental Barrier Membrane Market – The market analysis is further broken down into segments by:
- Material: Allografts, Xenografts (Bovine, Porcine), Synthetics.
- Type: Resorbable (Small, Medium, Large), Non-Resorbable (Small, Large (Non-Reinforced, Titanium-Reinforced))
- Antimicrobial Periodontal Treatment Market
*Segment is analyzed at a unit level only.
Research Scope Summary
Report Attribute | Details |
---|---|
Region | Asia Pacific (Australia) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2022 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |